PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Diatreme Resources Limited (DRX.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000DRX3

Sector

Basic Materials

IPO Date

Jun 22, 2005

Highlights

Market Cap

A$95.16M

Gross Profit (TTM)

-A$136.82K

EBITDA (TTM)

-A$1.04M

Year Range

A$0.02 - A$0.03

Target Price

A$0.35

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Diatreme Resources Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-26.92%
15.55%
DRX.AX (Diatreme Resources Limited)
Benchmark (^GSPC)

Returns By Period

Diatreme Resources Limited had a return of -13.64% year-to-date (YTD) and -13.64% in the last 12 months. Over the past 10 years, Diatreme Resources Limited had an annualized return of 8.99%, while the S&P 500 had an annualized return of 11.30%, indicating that Diatreme Resources Limited did not perform as well as the benchmark.


DRX.AX

YTD

-13.64%

1M

-9.52%

6M

-26.92%

1Y

-13.64%

5Y*

11.49%

10Y*

8.99%

^GSPC (Benchmark)

YTD

3.96%

1M

2.77%

6M

10.09%

1Y

21.57%

5Y*

12.62%

10Y*

11.30%

*Annualized

Monthly Returns

The table below presents the monthly returns of DRX.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-15.91%-13.64%
2024-4.17%-8.70%-2.38%-7.32%-10.53%11.76%42.11%-11.11%4.17%0.00%-4.00%-8.33%-8.33%
2023-11.11%-4.17%17.39%3.70%0.00%-17.86%0.00%-0.00%4.35%-8.33%9.09%0.00%-11.11%
20224.76%-13.64%10.53%14.29%33.33%9.38%11.43%0.00%-7.69%-2.78%-17.14%-6.90%28.57%
202111.11%10.00%0.00%-4.55%4.76%0.00%11.36%10.20%-14.81%-8.70%4.76%-4.55%16.67%
20208.33%-30.77%-11.11%0.00%0.00%12.50%33.33%-8.33%9.09%0.00%41.67%5.88%50.00%
2019-12.50%7.14%-13.33%0.00%-15.38%18.18%7.69%-14.29%-16.67%-0.00%10.00%9.09%-25.00%
201862.50%-23.08%15.00%-13.04%-0.00%5.00%4.76%-0.00%27.27%-25.00%-9.52%-15.79%-0.00%
201718.18%0.00%-23.08%-10.00%-11.11%12.50%11.11%10.00%36.36%-13.33%7.69%14.29%45.45%
201610.00%36.36%-6.67%7.14%-20.00%-0.00%-8.33%27.27%0.00%-21.43%-9.09%10.00%10.00%
2015-33.33%25.00%-0.00%20.00%-25.00%-11.11%25.00%20.00%-33.33%50.00%-33.33%25.00%-16.67%
2014-5.00%-15.79%-18.75%-15.38%0.00%-27.27%12.50%0.00%22.22%-27.27%112.50%-29.41%-40.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DRX.AX is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of DRX.AX is 3333
Overall Rank
The Sharpe Ratio Rank of DRX.AX is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of DRX.AX is 3434
Sortino Ratio Rank
The Omega Ratio Rank of DRX.AX is 3434
Omega Ratio Rank
The Calmar Ratio Rank of DRX.AX is 3737
Calmar Ratio Rank
The Martin Ratio Rank of DRX.AX is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Diatreme Resources Limited (DRX.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for DRX.AX, currently valued at -0.22, compared to the broader market-2.000.002.004.00-0.221.83
The chart of Sortino ratio for DRX.AX, currently valued at 0.09, compared to the broader market-6.00-4.00-2.000.002.004.006.000.092.47
The chart of Omega ratio for DRX.AX, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.33
The chart of Calmar ratio for DRX.AX, currently valued at -0.14, compared to the broader market0.002.004.006.00-0.142.76
The chart of Martin ratio for DRX.AX, currently valued at -0.79, compared to the broader market-10.000.0010.0020.0030.00-0.7911.27
DRX.AX
^GSPC

The current Diatreme Resources Limited Sharpe ratio is -0.22. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Diatreme Resources Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.22
2.07
DRX.AX (Diatreme Resources Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Diatreme Resources Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-96.47%
-1.59%
DRX.AX (Diatreme Resources Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Diatreme Resources Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Diatreme Resources Limited was 98.88%, occurring on Sep 3, 2015. The portfolio has not yet recovered.

The current Diatreme Resources Limited drawdown is 96.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.88%Jul 24, 20072056Sep 3, 2015
-43.24%Apr 3, 200661Jun 30, 2006131Jan 4, 2007192
-42.39%Jan 5, 2007124Jul 4, 20078Jul 16, 2007132
-30.45%Sep 20, 200554Dec 2, 200524Jan 10, 200678
-26.51%Jun 23, 200514Jul 12, 200529Aug 22, 200543

Volatility

Volatility Chart

The current Diatreme Resources Limited volatility is 16.94%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
16.94%
3.33%
DRX.AX (Diatreme Resources Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Diatreme Resources Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Diatreme Resources Limited compared to its peers in the Other Industrial Metals & Mining industry.


PE Ratio
20.040.060.080.00.0
The chart displays the price to earnings (P/E) ratio for DRX.AX in comparison to other companies of the Other Industrial Metals & Mining industry. Currently, DRX.AX has a PE value of 0.0. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
-10.0-5.00.05.00.0
The chart displays the price to earnings to growth (PEG) ratio for DRX.AX in comparison to other companies of the Other Industrial Metals & Mining industry. Currently, DRX.AX has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Diatreme Resources Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab